|
1.
|
Guharoy R, Noviasky J, Haydar Z, Fakih MG, Hartman C. Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm. Chest. 2013 Apr 1; 143(4):896-900.
|
|
|
|
|
2.
|
Xu R, Polk RE, Stencel L, Lowe DK, Guharoy R, Duggal RW, Wiest M, Putney KS, Flint NB. Antibiogram compliance in University HealthSystem Consortium participating hospitals with Clinical and Laboratory Standards Institute guidelines. Am J Health Syst Pharm. 2012 Apr 1; 69(7):598-606.
|
|
|
|
|
3.
|
Anagnostis E, Wordell C, Guharoy R, Beckett R, Price V. A national survey on hospital formulary management processes. J Pharm Pract. 2011 Aug; 24(4):409-16.
|
|
|
|
|
4.
|
Bush PW, Ashby DM, Guharoy R, Knoer S, Rough S, Stevenson JG, Wiest M. Pharmacy practice model for academic medical centers. Am J Health Syst Pharm. 2010 Nov 1; 67(21):1856-61.
|
|
|
|
|
5.
|
Guharoy R. It is time for food and drug administration reform. Arch Intern Med. 2010 Apr 26; 170(8):737.
|
|
|
|
|
6.
|
Lehmann DF, Page N, Kirschman K, Sedore A, Guharoy R, Medicis J, Ploutz-Snyder R, Weinstock RS, Duggan DB. Every error a treasure: improving medication use with a nonpunitive reporting system. Jt Comm J Qual Patient Saf. 2007 Jul; 33(7):401-7.
|
|
|
|
|
7.
|
Lehmann DF, Guharoy R, Page N, Hirschman K, Ploutz-Snyder R, Medicis J. Formulary management as a tool to improve medication use and gain physician support. Am J Health Syst Pharm. 2007 Mar 1; 64(5):464-6.
|
|
|
|
|
8.
|
Guharoy R. Missed opportunity for stem-cell research. Am J Health Syst Pharm. 2007 Jan 15; 64(2):136-8.
|
|
|
|
|
9.
|
Lehmann DF, Stork CM, Guharoy R. Hospital pharmacology: An alternative model for practice and training in clinical pharmacology. J Clin Pharmacol. 2006 Aug; 46(8):850-4.
|
|
|
|
|
10.
|
Guharoy R, Noviasky J. Ethical beliefs and professional duty. Am J Health Syst Pharm. 2005 Sep 15; 62(18):1864, 1866.
|
|
|
|
|
11.
|
Guharoy R. Risks of a nonprescription lovastatin. Am J Health Syst Pharm. 2005 Jul 15; 62(14):1444-5.
|
|
|
|
|
12.
|
Guharoy R. Potential and perils of implantable microchip. Am J Health Syst Pharm. 2005 Feb 15; 62(4):355.
|
|
|
|
|
13.
|
Guharoy R. Reform of U.S. vaccine management. Am J Health Syst Pharm. 2005 Feb 1; 62(3):247.
|
|
|
|
|
14.
|
Guharoy R, Gilroy SA, Noviasky JA, Ference J. West Nile virus infection. Am J Health Syst Pharm. 2004 Jun 15; 61(12):1235-41.
|
|
|
|
|
15.
|
Guharoy R, Panzik R, Noviasky JA, Krenzelok EP, Blair DC. Smallpox: clinical features, prevention, and management. Ann Pharmacother. 2004 Mar; 38(3):440-7.
|
|
|
|
|
16.
|
Marraffa J, Guharoy R, Duggan D, Rose F, Nazeer S. Vancomycin-induced thrombocytopenia: a case proven with rechallenge. Pharmacotherapy. 2003 Sep; 23(9):1195-8.
|
|
|
|
|
17.
|
Noviasky JA, Kelberman M, Whalen KM, Guharoy R, Darko W. Science or fiction: use of nesiritide as a first-line agent? Pharmacotherapy. 2003 Aug; 23(8):1081-3.
|
|
|
|
|
18.
|
Guharoy R, Noviasky JA. Time to ban ephedra--now. Am J Health Syst Pharm. 2003 Aug 1; 60(15):1580-2.
|
|
|
|
|
19.
|
Darko W, Medicis JJ, Smith A, Guharoy R, Lehmann DE. Mississippi mud no more: cost-effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicity. Pharmacotherapy. 2003 May; 23(5):643-50.
|
|
|
|
|
20.
|
Marraffa JM, Guharoy R. Lymphadenopathy secondary to lamotrigine (Lamictal). Vet Hum Toxicol. 2002 Oct; 44(5):276-7.
|
|
|
|
|
21.
|
Guharoy R. Drug safety and effectiveness in children. Am J Health Syst Pharm. 2002 Aug 15; 59(16):1569-70.
|
|
|
|
|
22.
|
Schachtner JM, Guharoy R, Medicis JJ, Newman N, Speizer R. Prevalence and cost savings of therapeutic interchange among U.S. hospitals. Am J Health Syst Pharm. 2002 Mar 15; 59(6):529-33.
|
|
|
|
|
23.
|
Darko W, Guharoy R, Rose F, Lehman D, Pappas V. Myoclonus secondary to the concurrent use of trazodone and fluoxetine. Vet Hum Toxicol. 2001 Aug; 43(4):214-5.
|
|
|
|
|
24.
|
Rolland WA, Guharoy R, Ramirez L, Blair D, Medicis J, Khan U. Respiratory distress secondary to both amphotericin B deoxycholate and lipid complex formulation. Vet Hum Toxicol. 2000 Aug; 42(4):222-3.
|
|
|
|
|
25.
|
Guharoy R, Medicis J, Chol S, Stalder B, Kusiowski K, Allen A. Methamphetamine overdose: experience with six cases. Vet Hum Toxicol. 1999 Feb; 41(1):28-30.
|
|
|
|
|
26.
|
Guharoy R, Medicis J, Lehmann D. Fatal adverse event secondary to high osmolality contrast agent. Vet Hum Toxicol. 1998 Oct; 40(5):285-7.
|
|
|
|
|
27.
|
Guharoy R. Preserve the FDA's authority. Am J Health Syst Pharm. 1996 Nov 1; 53(21):2636, 2638.
|
|
|
|
